348 related articles for article (PubMed ID: 28150854)
1. Imaging analyses of coagulation-dependent initiation of fibrinolysis on activated platelets and its modification by thrombin-activatable fibrinolysis inhibitor.
Brzoska T; Suzuki Y; Sano H; Suzuki S; Tomczyk M; Tanaka H; Urano T
Thromb Haemost; 2017 Apr; 117(4):682-690. PubMed ID: 28150854
[TBL] [Abstract][Full Text] [Related]
2. Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system.
Suzuki Y; Sano H; Mochizuki L; Honkura N; Urano T
Blood Adv; 2020 Nov; 4(21):5501-5511. PubMed ID: 33166409
[TBL] [Abstract][Full Text] [Related]
3. Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis.
Mochizuki L; Sano H; Honkura N; Masumoto K; Urano T; Suzuki Y
Thromb Haemost; 2023 Jan; 123(1):16-26. PubMed ID: 36307100
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor.
Ammollo CT; Semeraro F; Incampo F; Semeraro N; Colucci M
J Thromb Haemost; 2010 Apr; 8(4):790-8. PubMed ID: 20088944
[TBL] [Abstract][Full Text] [Related]
5. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
Morishima Y; Honda Y
J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
[TBL] [Abstract][Full Text] [Related]
6. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
Urano T
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
[TBL] [Abstract][Full Text] [Related]
7. Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets.
Schadinger SL; Lin JH; Garand M; Boffa MB
J Thromb Haemost; 2010 Nov; 8(11):2523-9. PubMed ID: 20723026
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
Whyte CS; Swieringa F; Mastenbroek TG; Lionikiene AS; Lancé MD; van der Meijden PE; Heemskerk JW; Mutch NJ
Blood; 2015 Apr; 125(16):2568-78. PubMed ID: 25712989
[TBL] [Abstract][Full Text] [Related]
9. Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models.
Leenaerts D; Loyau S; Mertens JC; Boisseau W; Michel JB; Lambeir AM; Jandrot-Perrus M; Hendriks D
J Thromb Haemost; 2018 Oct; 16(10):2057-2069. PubMed ID: 30053349
[TBL] [Abstract][Full Text] [Related]
10. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
11. Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin- activatable fibrinolysis inhibitor.
Shenkman B; Einav Y; Livnat T; Budnik I; Martinowitz U
Int J Lab Hematol; 2015 Aug; 37(4):521-9. PubMed ID: 25651468
[TBL] [Abstract][Full Text] [Related]
12. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets.
Ni R; Neves MAD; Wu C; Cerroni SE; Flick MJ; Ni H; Weitz JI; Gross PL; Kim PY
J Thromb Haemost; 2020 Sep; 18(9):2364-2376. PubMed ID: 32506822
[TBL] [Abstract][Full Text] [Related]
13. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.
Bajzar L; Nesheim ME; Tracy PB
Blood; 1996 Sep; 88(6):2093-100. PubMed ID: 8822928
[TBL] [Abstract][Full Text] [Related]
14. Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII.
Nielsen VG; Kirklin JK
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):793-800. PubMed ID: 19002046
[TBL] [Abstract][Full Text] [Related]
15. Regulation of plasminogen activation on cell surfaces and fibrin.
Urano T; Castellino FJ; Suzuki Y
J Thromb Haemost; 2018 May; 16(8):1487-97. PubMed ID: 29779246
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis.
Tomczyk M; Suzuki Y; Sano H; Brzoska T; Tanaka H; Urano T
Thromb Res; 2016 Jul; 143():28-33. PubMed ID: 27179129
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.
Binette TM; Taylor FB; Peer G; Bajzar L
Blood; 2007 Nov; 110(9):3168-75. PubMed ID: 17644733
[TBL] [Abstract][Full Text] [Related]
18. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
[TBL] [Abstract][Full Text] [Related]
19. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
20. Plasmin and the thrombin-thrombomodulin complex both contribute to thrombin-activatable fibrinolysis inhibitor activation in whole blood model thrombi.
Vercauteren E; Mutch NJ; Declerck PJ; Gils A
J Thromb Haemost; 2013 Jan; 11(1):190-2. PubMed ID: 23140098
[No Abstract] [Full Text] [Related]
[Next] [New Search]
